1) hepat-aneurysm
肝动脉瘤
1.
Objective To explore the experience of diagnosis and treatment for hepat-aneurysm.
目的 探讨肝动脉瘤的诊治经验。
2) Liver neoplasms·Hepatic artery·Embolization
肝肿瘤·肝动脉·栓塞
3) hepatic portal vein (hepatic artery)
肝门静脉(肝动脉)
4) Hepatic artery
肝动脉
1.
Biomechanical properties of hepatic artery in swine with portal hypertension;
门静脉高压症猪肝动脉的生物力学特性
2.
Protection of hyperbaric oxygen on liver injury in rat with hepatic artery ligation;
高压氧治疗肝动脉结扎大鼠肝损伤的探讨
3.
The clinical observation of hepatic artery and portal vein e mbolic chemotherapy in the treatment of Intermediate and advanced hepatocelluar carcinoma.;
肝癌肝动脉、门静脉双途径栓塞化疗的临床观察
5) hepatic artery
肝总动脉
1.
Objective:To discuss the lesion's blood supply of primay hepatic carcinoma(PHC) by hepatic artery routine angiography(RA) and long time low rate angiography(LTLRA), and to approach the sensititivity of lesion,s detection and measures of quality control(QC).
目的:研究原发性肝癌(PHC)经肝总动脉造影(RA)与长时程低流率造影(LTLRA)的病灶血供表现,及病灶检出的敏感性,并探讨其质量控制措施。
6) Liver artery
肝动脉
1.
Objective:To investigate the experience of vascular inosculation between liver artery and portal vein in orthotopic liver transplantation.
目的:总结同种异体原位肝移植术中肝动脉和门静脉吻合的经验。
2.
Methods: Thirty antiseptic adult liver specimens were studied for the laparoscopic applied anatomy of the liver artery.
目的 :为腹腔镜肝脏外科提供肝动脉的应用解剖及手术入路设计。
3.
ResultsThe patients were divided into three groups, group A (72 cases) were treated with chemical therapy by portal vein, group B (13 cases) were treated by liver artery and group C (31 cases) were treated by arterial chemoembolization.
结果经门静脉化疗72例(A组),肝动脉化疗13例(B组),经皮穿刺肝动脉化疗栓塞31例(C组);门静脉置化疗泵组复发时间为(16。
补充资料：动脉粥样硬化性动脉瘤
动脉粥样硬化性动脉瘤
atherosclerotic aneurysm
动脉管壁上的粥样斑块及动脉中层胶原纤维的透明变性使管壁遭到削弱，而形成动脉瘤。常呈梭形或呈念珠状，占动脉瘤总数的10%～18%。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条